Cardiovascular risk management in cancer survivors:Are we doing it right?  

作　　者：Turab Mohammed Tarang Parekh Aakash Desai 

机构地区：[1]Department of Medicine,University of Connecticut,Farmington,CT 06030,United States [2]Department of Health Administration and Policy,George Mason University,Fairfax,VA 22030,United States [3]Department of Hematology and Oncology,Mayo Clinic,Rochester,MN 55902,United States

出　　处：《World Journal of Clinical Oncology》2021年第3期144-149,共6页世界临床肿瘤学杂志（英文版）

摘　　要：Although under-recognized,cancer survivors continue to be at an increased risk of death from cardiovascular complications post-remission or cure.This increased burden of cardiovascular disease results from the interplay of various factors.Adequate cardiovascular risk assessment and timely intervention through a multi-disciplinary approach in these patients plays a pivotal role in the prevention of cardiovascular morbidity and mortality.We discuss the shortcomings of using current risk prediction scores in cancer survivors and provide some insights into cardiovascular risk management relevant for primary care physicians,oncologists,and cardiologists alike.

关 键 词：Cancer survivors Cardio-oncology Atherosclerotic cardiovascular disease risk estimator Cardiovascular disease risk Childhood cancer survivor study Cancer policy 

分 类 号：R730.6[医药卫生—肿瘤]